Search Results

You are looking at 51 - 60 of 171 items for :

  • malignant paraganglioma x
  • All content x
Clear All
Free access

David Taïeb, Abhishek Jha, Giorgio Treglia, and Karel Pacak

Jeunemaitre X Gimenez-Roqueplo AP, 2007 Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas . Journal of Clinical Endocrinology and Metabolism 3822 – 3828. ( https://doi.org/10

Free access

Jenny Welander, Peter Söderkvist, and Oliver Gimm

Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis . Endocrine-Related Cancer 17 561 – 579 . ( doi:10.1677/ERC-09-0310 ). The Cancer Genome

Free access

Frédéric Castinetti, Alexander Kroiss, Rakesh Kumar, Karel Pacak, and David Taieb

-Vega LJ Buffet A De Cubas AA Cascon A Menara M Khalifa E Amar L Azriel S Bourdeau I Chabre O 2014 Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas . Human Molecular Genetics 23

Free access

Esther Korpershoek, Bart-Jeroen Petri, Francien H van Nederveen, Winand N M Dinjens, Albert A Verhofstad, Wouter W de Herder, Sonja Schmid, Aurel Perren, Paul Komminoth, and Ronald R de Krijger

–836. Brouwers FM , Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM & Pacak K 2006 High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for

Free access

Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, and Faidon Harsoulis

Malignant Pheo / PGL RET + + ++ − − Pheo VHL + ++ +++ + ± Pheo SPgl SDHD + ± + +++ ± Pheo SPgl PPgl SDHB + ± + +++ +++ Pheo SPgl PPgl NF1 + ± ± Clinical criteria of NF1 Pheo SPgl SPgl, sympathetic paraganglioma; PPgl, parasympathetic paraganglioma

Free access

Arthur Varoquaux, Electron Kebebew, Fréderic Sebag, Katherine Wolf, Jean-François Henry, Karel Pacak, and David Taïeb

Maier W Bausch B Schipper J Ridder GJ 2007 Malignant head and neck paragangliomas in SDHB mutation carriers . Otolaryngology – Head and Neck Surgery 137 126 – 129 . ( doi:10.1016/j.otohns.2007.01.015 ) Dong Y Liu Q 2012

Free access

Ales Vicha, David Taieb, and Karel Pacak

predisposition to malignant pheochromocytomas and paragangliomas . Human Molecular Genetics 23 2440 – 2446 . ( doi:10.1093/hmg/ddt639 ). Cervera AM Bayley JP Devilee P McCreath KJ 2009 Inhibition of succinate dehydrogenase dysregulates histone

Free access

H J L M Timmers, F M Brouwers, A R M M Hermus, F C G J Sweep, A A J Verhofstad, A L M Verbeek, K Pacak, and J W M Lenders

Phaeochromocytoma . Lancet 366 665 – 675 . Linnoila RI Keiser HR Steinberg SM Lack EE 1990 Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features . Human

Free access

Alberto Cascón, Lucía Inglada-Pérez, Iñaki Comino-Méndez, Aguirre A de Cubas, Rocío Letón, Jaume Mora, Mónica Marazuela, Juan Carlos Galofré, Miguel Quesada-Charneco, and Mercedes Robledo

Dear Editor: Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors that arise from the adrenal medulla or from the extra-adrenal sympathetic and parasympathetic paraganglia respectively. Now we know that more than 30% of

Free access

Sophie Moog, Charlotte Lussey-Lepoutre, and Judith Favier

Silvera S Bertherat J Bertagna X Schlumberger M Jeunemaitre X Gimenez-Roqueplo AP 2007 Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas . Journal of Clinical